Use of quetiapine in bipolar disorder: a case series with prospective evaluation

被引：21

作者：

Suppes, T ^{[1
]}

McElroy, SL ^{[1
]}

Keck, PE ^{[1
]}

Altshuler, L ^{[1
]}

Frye, MA ^{[1
]}

Grunze, H ^{[1
]}

Leverich, GS ^{[1
]}

Nolen, WA ^{[1
]}

Chisholm, K ^{[1
]}

Dennehy, EB ^{[1
]}

Post, RM ^{[1
]}

机构：

[1] UT SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA

来源：

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2004年 / 19卷 / 03期

关键词：

bipolar disorder; maintenance; outpatient; polypharmacy; quetiapine; treatment;

D O I：

10.1097/00004850-200405000-00010

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Quetiapine, a new atypical antipsychotic, was added to ongoing treatment of bipolar I outpatients (n=15) for symptoms of illness (mood lability, irritability, psychosis and/or difficulty sleeping). All evaluations were prospectively obtained, with the majority of patients (n=9) showing much or very much improvement on the Clinical Global Impression for Bipolar Disorder (CGI-BP). Somatic complaints were limited. Mean (SD) duration before changes in medication regimens was 134 (100) days. Studies of the use of quetiapine in maintenance treatment of bipolar disorder are warranted. (C) 2004 Lippincott Williams Wilkins.

引用

页码：173 / 174

页数：2

共 6 条

[1] Extending indications for long-term pharmacotherapy: Opportunities and challenges [J].